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COMPARISON OF LENGTH OF ANESTHESIA USING THE VASOCONSTRI~ORS,
EPINEPHRINE AND PHENYLEPHRINE, WITH PROCAINE, CARBOCAINE~*
AND LIDOCAINE
INTRODUCTION

I.

A.

Background of local anesthetics.
In a list of medical discoveries which have greatly influenced
the course of medical practice one would surely have to include
the discovery of local anesthetics.
Niemann was the first to observe in 1860 that an alkaloid,
cocaine, when placed on the tongue, caused a sensation of
numbness.

Although other pioneers are mentioned in connection

with experiments with cocaine, it remained for Sigmund Freud and
Karl Koller in 1884 to develop the practical application of cocaine
as a local anesthetic to medical practice.

A short time later

Halstead in the United States started investigations which led
to the discovery of nerve blocks.

In 1905 Einhorn introduced

procaine, a synthetic local anesthetic which displayed less
toxicity than cocaine and did not promote addiction.

Since

then, numerous local anesthetics have been synthesized, displaying various degrees of anesthesia, toxicity and duration
of action.
Many of the Common local anesthetics are esters of amino
alcohols and aminobenzoic acid.
an ionized form.

When injected they are in

In this form they are transported to the

nerve tissue where the alkaline environment changes the drug
* Carbocaine is the trade name of Winthrop Laboratories for
mepivacaine.
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to an un-ionized form. 2 Although the mechanism of action of
local anesthetics isn't completely understood it is thought
that this un-ionized form depolarizes the nerve membrane so that
conduction is interrupted.

Thus, poor anesthesia is obtained in

an infected area because of the acidic environment which keeps
the anesthetic ionized.

Pain disappears first, then cold,

warmth, touch and deep pressure.
It has been noted that the time required for induction of a
blockage by a particular drug varies inversely with the concentration of the drug and directly with the square of the
radius of the nerve.

-

However, duration of anesthesia is

usually affected by concentration also, with the higher concentrations lasting longer than the very dilute solutions.
Above certain concentrations (which are actually quite dilute
solutions) no practical increase in anesthesia is obtained but
increased toxicity with danger to the patient is found.
Most local anesthetics do have certain toxic actions which
can produce very serious effects on the patient when used
incorrectly.

Local toxicity is demonstrated by the damage to

tissue due to the effects of the drug at the site of injection.
Systemic toxicity is manifest by reactions which are usually
due to an increased blood concentration of the anesthetic.
This can be caused by giving too great a quantity of anesthetic,
too rapid absorption, giving the anesthetic intravascularly, or
--""-
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insufficient destruction of the anesthetic.

A few reactions

have been explained on a hypersensitivity and anaphylactoid
basis.
One means of better controlling absorption of local anesthetics
has been the addition of vasoconstrictor substances to the
anesthetic.

This causes local vasoconstriction of the vessels,

slowing down spread and absorption of the anesthetic.

It permits

the use of less anesthetic and makes possible more intense and
more prolonged anesthesia without an increase in quantity of
anesthetic.

This results in a decrease in severity and frequency

of toxic symptoms due to absorbed anesthetic agents.
Campbell and Adriani 4 found that using 1:100,000 epinephrine
with procaine decreased certain signs of toxicity from the procaine by 30%.

The optimal concentration of epinephrine to use

with local anesthetics was studied by Keesling and Hinds 14 who
noted that a solution of 1/250,000 epinephrine was as effective
in increasing depth and duration of anesthesia as 1/50,000 or
1/100,000 concentrations.

(Lidocaine was the only anesthetic

used) •
Another advantage to a vasopressor in a local anesthetic is
that it decreases hemorrhage at the site of an operation or
laceration.
Disadvantages of using a vasoconstrictor could probably be
listed as:
1.

Danger to tissues if injected into an area with a
blood supply consisting of end arteries.
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B.

2.

Danger of too much epinephrine being mixed with
the anesthetic and causing toxic symptoms.

3.

Inconvenience of adding a second drug to the local
anesthetic being used.

4.

Contraindications: Hypertension, severe arteriosclerosis, pheochromocytoma, and thyrotoxicosis.

Drug Description.
1.

Procaine.
Of the three local anesthetic agents used in this study,
procaine is the most common.

It is an amino ester made from

an amino alcohol and para-amino benzoic acid and is soluble
in water to the extent of 1 gram in 1 cc. of water.

It is

still probably the most widely used of currently available
local anesthetics.

Procaine produces fairly good anesthesia

and has little toxicity except in larger doses.

It is not

very effective as a topical anesthetic as it is poorly absorbed from the mucous membranes.

Procaine is used as the

standard for toxicity and potency in comparing injectable
anesthetics.

A rate of about 1 gram per hour appears to be

tolerated by man.
Usually 1 or 2 per cent solutions are used but 4 per cent
is used for some dental extractions.
2.

Lidocaine.
Lidocaine

(Xylocain~* was synthesized by Loefgren in 1943

and is readily water soluble and stable.

It was derived from

* Xylocaine is the trade name used by Astra Pharmaceutical Products,
Inc., for lidocaine.
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acetanilide and is somewhat greater in toxicity and potency
than procaine.

Maximum doses per injection is generally

thought today as one half of that for procaine, or 500 mg.
It is effective topically on mucous membranes whereas
procaine is not.

Lidocaine is usually used in one half to

two per cent solutions for infiltration.
3.

Carbocaine.
Carbocaine is a comparatively new local anesthetic synthesized in 1956.

It has a greater potency and it seems to
Luduena 16 and his group

be less irritating than procaine.

found that carbocaine had twice the duration of action of
lidocaine.

He also found that carbocaine injected into mice

was twice as toxic as procaine but was less toxic than
lidocaine.

Maximum dose per injection in man is presently

recommended at 500-750 mg.
4.

Epinephrine

(Adrenalin~ Suparareni~*

This is a substance which is produced in the body by the
adrenal medulla.

It is also synthetically made in the laboratory.

It's action is adrenergic:

constriction of most arteries and

veins, constriction of mucous membranes, cardio acceleration,
relaxed bronchi, etc.
Administration is usually parenteral as there is poor response when administered orally.
Inactivation is usually quite

.-

r~pid

and is thought to be

accomplished through several enzyme systems capable of
* Adrenaline is Parke Davis trade name and Suprarenin is the
Winthrop trade name for epinephrine solutions.
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inactivating the dehydroxyphenyl adrenergic amines.
This is a very potent drug and usual therapeutic doses
will produce minor toxic symptoms (anxiety, tremor, headache,
palpitations).

These do not usually last long and are not

thought to be dangerous.

Overdosage produces toxic effects

which can be fatal, however.

These include cerebrovascular

hemorrhage produced from the elevated arterial pressure,
pulmonary edema from pulmonary arterial hypertension, and
ventricular hyperirritability.

Dose for any parenteral

route other than intravenous is 1 mg. or less.

With local

anesthetics the concentration of epinephrine is usually
1:100,000 or 1:200,000, although in dental practice a concentration of 1:60,000 is often used.
5.

Phenylephrine (Neo-Synepbrin~*
This vasopressor drug is less potent than levarterenal and
has a little longer duration of action.

Parenteral adminis-

tration in humans produces peripheral vasoconstriction,
increased arterial pressure, and reflex bradycardia.

It does

not stimulate cardiac tissue to the degree that epinephrine
does nor does it produce central stimulation.
Doses often advocated are:

0.5 mg. intravenously, 5 mg.

subcutaneously, or 250 mg. orally.

In local anesthetics it

is used in concentrations of 1:2500 to 1:54,000.

* Neo-Synephrine is the trade name of the Winthrop Laboratories
for phenylephrine.
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II.

PURPOSES OF STUDY
The effects of local anesthetics in inhibiting pain has been
studied on nerve specimens, animals and man.

Although experiments

on laboratory animals and specimens usually produce more accurate
values and afford more reliable duplication of results, the findings
do not necessarily apply to man.

Pain is a subjective phenomenon

which is very difficult to study in animals.

Therefore, any final

test of pain inhibiting drug which is to be used primarily on
humans must ultimately be tested on humans.
The purpose of this study was first to compare the length of
anesthesia of three local anesthetics; procaine, lidocaine and
carbocaine.

The second purpose was to compare the three local

anesthetics without a vasoconstrictor to similar solutions with
(a) epinephrine and (b) phenylephrine added.

A third comparison

to be noted is what differences, if any, exist between local
anesthetics with epinephrine added and anesthetics with phenylephrine
added.

Interest here is focused particularly on the use of phenyl-

ephrine, as this is not commonly used with local anesthetics.
Epinephrine is the main vasoconstrictor used with local anesthetics.
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III.

METHOD
Early in the study, it was hoped that we could use a small

electric nerve stimulator with a method of injecting materials
around the nerve which was to be blocked.

However, this

necessitated 10 different injections into the area around the
same nerve, each of which required considerable time as well as
a danger of injury to the nerve with so many injections.
Therefore, we decided to use intracutaneous injections into
the anterior surface of the forearms.
A.

Test substances (10 different items)
1.

Procaine, lidocaine, carbocaine, 1% solutions.

2.

Procaine, lidocaine, carbocaine, 1% solutions
with 1:200,000 epinephrine added.

3.

Procaine, lidocaine, carbocaine, 1% solutions
with 1:25,000 phenylephrine added.

4.

Saline, normal.
These test drugs were prepared by Dr. J. Jones and placed

in bottles which had only an alphabetic letter on them.

The

exact contents of each bottle was known only to Dr. Jones
until the study was completed.

The pH of each test drug

was determined before and after testing with little change
noted.
B.

Procedure
One milliliter from each bottle was injected, subcutaneously,
using 25 gauge needles, into a cleaned area on the anterior
forearms of each volunteer, care being taken that the injection
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sites were properly spaced to avoid overlapping of anesthesi~.
Each wheal was marked with the letter indicating which test
drug had been injected.

The same drugs were not used in

exactly the same areas on each volunteer but were rotated
around the various areas.

c.

Testing the degree of anesthesia.
Each volunteer was given essentially the same amount of
information about the study and instructions they were to
follow.

None of them knew what were in the test bottles.

Each volunteer was asked to check the various test sites every
5 minutes in order to ascertain when the anesthesia wore off.
They were instructed to use 25 gauge needles in testing for
loss of pain and to use approximately the same amount of
pressure on each test site in determining anesthesia.

Mimeo-

graphed sheets were made and on which the volunteers marked
the (a) time when the injection was made; (b) time of onset
of anesthesia; (c) time when some pain first came back into
the area and (d) that time when pain sensation had completely
returned.
Any toxic signs or symptoms, whether local or of a more
systemic nature, were to be noted.
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IV.

RESULTS AND BISCUSSION
Anesthesia was almost invariably complete immediately after the

injection of one milliliter of the test drug.

The area of anesthesia

was usually limited to the area of the original wheal formation.
When 2 milliliters of test drug was used, considerable overlapping of anesthesia was noted, particularly distal to the wheal.
Also greater burning was noted upon injection of the drug.
Therefore, 1 milliliter was used throughout the study.
The length of time from the onset of anesthesia until the first
detectable pain sensation was noted in each case and an average
length of anesthesia in minutes determined for each test drug

.-

(Table I).

When these are compared with the average length of

anesthesia from onset until complete return of pain sensation to
pin prick (Table 2), it is noted that most volunteers detected
some return of pain from 20 to 60 minutes before pain sensation
had completely returned.

This is indicative of the diffusion of

the anesthetic into the tissues and blood stream and gradual
return of normal function to the nervous tissue involved.
Table 2 gives the range of values as well as the mean anesthesia
time for each test drug.

These values are the number of minutes

from onset of anesthesia until complete return of pain sensation
to pin prick.
A comparison of the average length of anesthesia of procaine,
carbocaine, and lidocaine show that anesthesia lasted about 66%
longer in the cases of lidocaine and carbocaine over procaine.
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However the range of values was considerably wider with lidocaine
and carbocaine.

This does not agree with Luduena 16 and his group

who found that carbocaine had twice the duration of action of
lidocaine.
procaine.

Lidocaine is thought to be about twice as potent as
Our results show procaine with a mean length of anesthesia

of 61.5 minutes and lidocaine with a mean length of anesthesia of
102.6 minutes.
When epinephrine was added to carbocaine a 50% increase in the
average length of anesthesia time was noted.

In comparing carbo-

caine with epinephrine and carbocaine without epinephrine, we have
a standard error of the difference between the two means of 17.4
minutes and a relative deviate of 2.76.

This shows we are out on

the far sides of our distribution curve a distance of 2.76 standard
errors.

In a normal distribution 99% of the values lie within

2.6 standard errors of the mean.

This would give us a proba-

bility (p) of less than 0.01, in which case we can conclude that
something other than chance caused the difference in our two
samples.

In this case the presence of epinephrine is the one known

differing factor and we can conclude that it probably caused the
increased length of anesthesia time.
Procaine with epinephrine added showed a mean anesthesia time
increase from 61.5 minutes to 214.0 minutes.

Comparing the

procaine with epinephrine (test item) with the procaine without
epinephrine (control sample) we find that our relative deviate
is 4.8 which statistically is very significant.
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(When out 3

standard errors from the mean, 99.73% of the values are included).
Here also we can conclude that random sampling or chance couldn1t
have caused this large a variation between the two test items.
Lidocaine with epinephrine showed about 100% increase in mean
anesthesia time.

However, there was a wide dispersion of the

values so that there was a standard error of the mean of 42 minutes with a standard error of the difference between the 2 means
(lidocaine with and without epinephrine) of 46.0 minutes.

The

relative deviate was 2.3 which would give a probability of about
0.03. (When out two standard errors you are at the 95 percentile
and have a probability of 0.05 which has borderline significance).
A probability of 0.03 is statistically significant and we would
conclude that the

~pinephrine

added to the lidocaine probably

caused the increase in anesthesia time.
When phenylephrine was added to carbocaine the mean anesthesia
time increased from 103.5 minutes to 238.7 minutes.

The relative

deviate was 6.5 which is very significant statistically.
Procaine with phenylephrine added increased very little in
mean anesthesia time (61.5 to 76.7).

In comparing procaine with

and without phenylephrine the relative deviate was 1.36.
would be about the 75th percentile.

This

Thus, in future samples of

these test items there would be 25% of them with differences as
great as or greater than those in our actual study and could be
due to chance.

Therefore, the small increase in mean anesthesia

time observed with the phenylephrine added to the procaine is not
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statistically significant and could be due to chance.
Lidocaine increased in mean anesthesia time from 102.6 minutes
to 220.4 minutes with phenylephrine added.

It had a relative

deviate of 4.03 which indicates that this difference in anesthesia
time between the lidocaine containing phenylephrine and the lidocaine without phenylephrine is significant and is probably due to
the phenylephrine and not due to chance.
In comparing the two vasoconstrictors used in this study, it
can be seen that when added to lidocaine the mean anesthesia
times are about the same but the range of values of the lidocaine
and epinephrine causes it to have less statistical significance
than the lidocaine with phenylephrine added.
The large difference in mean anesthesia time between the two
vasoconstrictors added to procaine has already been mentioned.
The lack of re?ponse of phenylephrine with procaine will have to
remain unexplained for the present.
Carbocaine with phenylephrine showed a significantly longer
mean anesthesia time than when epinephrine was added.

FUrther

studies involving various concentrations of these two vasoconstrictors as well as different concentrations of the anesthetics
would help in explaining differences noted in mean anesthesia time.
No similar studies using phenylephrine with local anesthetics were
found in order to compare results.

One volunteer had anesthesia

of the area in which normal saline was injected.

This could have

been caused by injecting the saline around the cutaneous nerve
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supplying this area with enough pressure to cause a disruption of
nerve impulses.

His anesthesia lasted for 101 minutes.

When

this test was repeated a few weeks later he experienced no
anesthesia.
No systemic reaction to the test items were noted.

The only

local "reactions" noted were small red papules on certain wheals
of some volunteers.

No consistency involving certain test drugs

causing these small red papules was noted.
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V.

CONCLUSIONS
Lidocaine and carbocaine exhibited about a 70% greater mean
anesthesia time than procaine.

These two anesthetics (lidocaine

and carbocaine) had mean anesthesia times which were within one
minute of each other indicating similar potency at these concentrations and for subcutaneous injections.
When epinephrine was added to the local anesthetics, they all
had significant increases in duration of anesthesia, although
larger increases were noted with lidocaine and procaine, the
latter not being statistically as significant due to the wide
range of the observations.
Phenylephrine is not considered as potent a vasoconstrictor
as epinephrine but significant increases in duration of anesthesia
were noted when phenylephrine was added to carbocaine and lidocaine.
The mean anesthesia time of the carbocaine and phenylephrine was
about 50% more than when epinephrine was added to the carbocaine.
The reason for phenylephrine producing these results with carbocaine but causing little increase in duration of anesthesia when
added to procaine remains unexplained.
From this study we can conclude that phenylephrine added to
carbocaine or lidocaine (in the amounts used) does as well in
prolonging local anesthesia time as when epinephrine is added as
the vasoconstrictor.

It also can be concluded that little, if

any, change is noted in duration of anesthesia when phenylephrine
is added to procaine.
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The use of epinephrine, of necessity, must be limited in patients
with hypertension, arteriosclerosis, cardiac arrhythmias, angina,
coronary thrombosis and diseases of hypermetabolism such as
thyrotoxicosis.

The fact that phenylephrine prolonged the anesthesia

time as long as epinephrine indicates that the local anesthetic is
not absorbed any faster with the former vasopressor as with the
latter.

This would indicate that phenylephrine should be used in

place of epinephrine in patients with the before mentioned disease
states.
Further investigations should include larger populations as
well as using different and varied concentrations of the vasoconstrictors and the anesthetics.

As was stated earlier, pain is

a subjective finding, the detection and degree of which is difficult
to determine and evaluate.

If changes in pain sensation are care-

fully noted and recorded however, statistically significant data
can be obtained.
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SUMMARY
It has been known for many years that vasoconstrictors prolong
the duration of anesthesia when added to local anesthetics.
However, there are few studies involving specific anesthetics with
specific vasoconstrictors and their effect on humans.

Epinephrine

is the vasoconstrictor usually used with local anesthetics.

Other

vasoconstrictors are rarely used for this purpose.
The object of this study was to find out what differences
existed between three local anesthetics, procaine, lidocaine and
carbocaine as to duration of anesthesia, both with and without
vasoconstrictors added.

Using two different vasoconstrictors,

epinephrine and phenylephrine, a further comparison could then
be drawn between these two for effectiveness in prolonging
anesthesia.
The method consisted of intracutaneous injections in the forearms
of ten volunteers who then measured degree and length of anesthesia
by checking for pain by pin prick.

Ten injections of 1 cc. each

were made on each volunteer; a 1% solution of each anesthetic
(procaine, lidocaine and carbocaine), a 1% solution of each
anesthetic with 1/200,000 epinephrine added, 1% solutions of each
anesthetic with 1/25,000 phenylephrine added, and an injection
consisting of 1 cc. of normal saline.
Lidocaine (102.6 minutes) and carbocaine (103.5 minutes) had
about twice the mean anesthesia time as procaine.
When epinephrine was added, an increase of mean anesthesia

- 17 -

time ranged from a 50% increase for carbocaine to a 250% increase
for procaine.

Lidocaine with epinephrine had a marked increase

in mean anesthesia time but the values fell over such a wide
range that its statistical significance was not as great as when
procaine and carbocaine solutions with epinephrine were compared
to solutions without epinephrine.
Procaine with phenylephrine showed little increase in mean
anesthesia time.

Lidocaine and carbocaine however, showed in-

creases in duration of anesthesia time as great or greater than
when epinephrine was used.

These were also statistically significant.

This study indicates that phenylephrine, when used with lidocaine
or carbocaine and in the concentrations used in this study, would
perform as well as epinephrine and would be particularly useful
with those patients who have hypertension, thyrotoxicosis, arteriosclerosis and other disease states in which the use of epinephrine
is rather limited.
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Mean
61.5

Procaine

standard
Deviation

Standard
Error of the
Mean

20.5

6.5

Procaine with
epinephrine

214.0

96.4

31.0

Lidocaine

102.6

58.4

18.7

Lidocaine with
epinephrine

209.8

130.3

41.9

Carbocaine

103.5

37.1

12.0

Carbocaine with
epinephrine

Procaine
Procaine with
phenylephrine
Lidocaine

152.0

40.1

12.9

61.5

20.5

6.5

76.7

27.4

8.7

102.6

58.4

18.7

Lidocaine with
phenylephrine

220.4

69.3

22.3

Carbocaine

103.5

37.1

12.0

Carbocaine with
phenylephrine

TABLE 3.

238.7

56.0

Standard
E:r:nr of the
Dl erence
Between Means

Relative
Deviate

31.3

4.8

46.0

2.3

17.4

2.76

11.0

1.36

29.0

4.03

21.3

6.5

18.1

Statistical Data (mean, standard deviation, standard error of the
mean, standard error of the difference between two means are all
given in minutes).
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